New Frontier Health Corporation Ordinary Shares
NFH was delisted on the 26th of January, 2022.
0 hedge funds and large institutions have $0 invested in New Frontier Health Corporation Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $208M → $0 (-$208M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$171M |
| 2 |
MCP
Maso Capital Partners
Hong Kong
|
-$36.6M |
NFH Hedge Fund Activity: Q2 2022 in Review
0 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Ordinary Shares (NFH) for Q2 2022, worth a combined $0 — down 100% from $208M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NFH and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vivo Capital, exiting entirely with an estimated $171M sold.
- 0 institutional investors held New Frontier Health Corporation Ordinary Shares (NFH) as of Q2 2022, down from 2 in Q1 2022.
- Funds reported $0 of New Frontier Health Corporation Ordinary Shares stock for Q2 2022, down 100% quarter-over-quarter.
- 0 funds opened new New Frontier Health Corporation Ordinary Shares positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest New Frontier Health Corporation Ordinary Shares seller in Q2 2022 was Vivo Capital, an estimated $171M sold.
Based on aggregated 13F filings for Q2 2022.